Intestinal dysbiosis: An emerging cause of pregnancy complications?

Medical Hypotheses

Volumn 84, Issue 3, 2015, Pages 223-226

  Zhang, Dongxin ^a   Huang, Yinping ^b   Ye, Duyun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EVALUATION; DYSBIOSIS; FEMALE; FETUS GROWTH; FETUS MORTALITY; HUMAN; HYPOTHESIS; INTESTINE FLORA; MALADJUSTMENT; MATERNAL MORTALITY; MORBIDITY; MOTHER FETUS RELATIONSHIP; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; ADAPTATION; BIOLOGICAL MODEL; COMPLICATION; INTESTINE; MICROBIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS;

ADAPTATION, PHYSIOLOGICAL; DYSBIOSIS; FEMALE; HUMANS; INTESTINES; MODELS, BIOLOGICAL; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84925366377     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.12.029     Document Type: Article

References (39)

1. Betz A.G. Immunology: tolerating pregnancy. Nature 2012, 490:47-48.
2. Freemark M. Placental hormones and the control of fetal growth. J Clin Endocrinol Metab 2010, 95:2054-2057.
3. Newbern D., Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 2011, 18:409-416.
4. Trowsdale J., Betz A.G. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 2006, 7:241-246.
5. Lain K.Y., Catalano P.M. Metabolic changes in pregnancy. Clin Obstet Gynecol 2007, 50:938-948.
6. Nelson S.M., Matthews P., Poston L. Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Hum Reprod Update 2010, 16:255-275.
7. Schumacher A., Heinze K., Witte J., et al. Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance. J Immunol 2013, 190:2650-2658.
8. Chen J.Z., Sheehan P.M., Brennecke S.P., Keogh R.J. Vessel remodelling, pregnancy hormones and extravillous trophoblast function. Mol Cell Endocrinol 2012, 349:138-144.
9. Linzer D.I., Fisher S.J. The placenta and the prolactin family of hormones: regulation of the physiology of pregnancy. Mol Endocrinol 1999, 13:837-840.
10. Redman C.W., Sargent I.L. Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594.
11. Noris M., Perico N., Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 2005, 1:98-114.
12. Spaanderman M., Ekhart T., van Eyck J., de Leeuw P., Peeters L. Preeclampsia and maladaptation to pregnancy: a role for atrial natriuretic peptide?. Kidney Int 2001, 60:1397-1406.
13. Young B.C., Levine R.J., Karumanchi S.A. Pathogenesis of preeclampsia. Annu Rev Pathol 2010, 5:173-192.
14. Kamada N., Seo S.U., Chen G.Y., Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013, 13:321-335.
15. Sekirov I., Russell S.L., Antunes L.C., Finlay B.B. Gut microbiota in health and disease. Physiol Rev 2010, 90:859-904.
16. Spor A., Koren O., Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 2011, 9:279-290.
17. Slack E., Hapfelmeier S., Stecher B., et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009, 325:617-620.
18. Salzman N.H., Hung K., Haribhai D., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010, 11:76-83.
19. Wu G.D., Chen J., Hoffmann C., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108.
20. Koren O., Goodrich J.K., Cullender T.C., et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012, 150:470-480.
21. Konstantinov S.R., van der Woude C.J., Peppelenbosch M.P. Do pregnancy-related changes in the microbiome stimulate innate immunity?. Trends Mol Med 2013, 19:454-459.
22. Evans J.M., Morris L.S., Marchesi J.R. The gut microbiome: the role of a virtual organ in the endocrinology of the host. J Endocrinol 2013, 218:R37-47.
23. Hawrelak J.A., Myers S.P. The causes of intestinal dysbiosis: a review. Altern Med Rev 2004, 9:180-197.
24. Chow J., Tang H., Mazmanian S.K. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol 2011, 23:473-480.
25. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009, 9:313-323.
26. Laitinen K., Poussa T., Isolauri E. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr 2009, 101:1679-1687.
27. Vijay-Kumar M., Aitken J.D., Carvalho F.A., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010, 328:228-231.
28. Carvalho F.A., Koren O., Goodrich J.K., et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 2012, 12:139-152.
29. Sibai B.M., Frangieh A. Maternal adaptation to pregnancy. Curr Opin Obstet Gynecol 1995, 7:420-426.
30. Granger J.P. Maternal and fetal adaptations during pregnancy: lessons in regulatory and integrative physiology. Am J Physiol Regul Integr Comp Physiol 2002, 283:R1289-1292.
31. Arck P.C., Hecher K. Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med 2013, 19:548-556.
32. Buchanan T.A., Xiang A.H. Gestational diabetes mellitus. J Clin Invest 2005, 115:485-491.
33. Collado M.C., Isolauri E., Laitinen K., Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008, 88:894-899.
34. Manco M., Putignani L., Bottazzo G.F. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010, 31:817-844.
35. Greiner T., Backhed F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab 2011, 22:117-123.
36. Howitt M.R., Garrett W.S. A complex microworld in the gut: gut microbiota and cardiovascular disease connectivity. Nat Med 2012, 18:1188-1189.
37. Ait-Belgnaoui A., Durand H., Cartier C., et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 2012, 37:1885-1895.
38. Xu Z., Zhao J., Zhang H., et al. Spontaneous miscarriages are explained by the stress/glucocorticoid/lipoxin A4 axis. J Immunol 2013, 190:6051-6058.
39. Lin F., Yu X., Zhang X., et al. A synthetic analog of lipoxin A4 partially alleviates dexamethasone-induced fetal growth restriction in rats. Placenta 2013, 34:941-948.